Algo version: 0.98b
RGC is listed at the NASDAQ Exchange
RGC [RGC]
NASDAQ Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is RGC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Regencell Bioscience 10 years ago, but if you had invested on Friday 16th of July 2021 when the price was $10.50, you would have made a loss of $-3.81 per share or -36.29%

Yes, the average daily trading liquidity for Regencell Bioscience is $1.43 million. You should therefore be able to get in and out of your positions relatively fast.

Regencell Bioscience has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 3.32, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Regencell Bioscience to be low [0.3 out of 1]